Xpert MTB/RIF assay
Jump to navigation
Jump to search
Indications
- assessment of tuberculosis
Clinical significance
- can detect active tuberculosis
- can also identify genetic markers that confer resistance to rifampin[1]
Procedure
- turnaround time = 2 hours
Notes
More general terms
References
- ↑ Jump up to: 1.0 1.1 Physician's First Watch, Julu 29, 2013 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
FDA MedWatch. July 25, 2013 FDA permits marketing of first U.S. test labeled for simultaneous detection of tuberculosis bacteria and resistance to the antibiotic rifampin. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm362602.htm - ↑ Jump up to: 2.0 2.1 Theron G et al Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. The Lancet, Early Online Publication, 28 October 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24176144 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)62073-5/abstract